Venus Remedies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/11/2025 ,inter alia, to consider and approve Board Meeting scheduled to be ....
VENUSREM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Venus Remedies Ltd has informed the BSE that its Board of Directors will meet on 10th November 2025. The main agenda is to consider and approve the Unaudited Standalone and Consolidated Financial Results for the quarter and half-year ended 30th September 2025 (i.e., Q2 FY26 results). The notice also states that any other business may be taken up with the Chair's permission. Additionally, the trading window for designated persons has been closed from 1st October 2025 and will reopen 48 hours after the results are declared, in line with insider trading regulations. The filing is a routine, procedural announcement with no financial figures disclosed at this stage.
This is a standard regulatory disclosure with no immediate impact on shareholders or stock price. Investors should watch for the actual Q2 FY26 results on or after 10th November 2025, which will provide the first real data point on the company's financial performance for the quarter. The closed trading window simply restricts insider trading until results are made public.